SastaSundar Ventures Ltd, a Kolkata-based digital healthcare firm, has unveiled an ambitious plan to invest Rs. 150 crore over the next two years in technology, warehousing, and generics-driven retail to steer the company back to profitability by FY26. This investment, primarily funded by proceeds from its Flipkart Health exit and internal reserves, will support the expansion of its B2C platform, the development of AI-powered healthcare tools, and the rollout of its generic medicines brand JITO.